Bora Pharmaceuticals small molecule drug product capabilities and Maple Grove facility overview

On-demand webinar

Explore how Bora Pharmaceuticals supports pharmaceutical companies through integrated global CDMO services, small molecule drug product capabilities, and development-to-commercial scale-up support. In this on-demand webinar, Bora leaders provide an overview of the company’s global manufacturing network and the advanced capabilities of the Maple Grove, Minnesota facility, including pharmaceutical development, tech transfer, pilot-scale manufacturing, commercial production, packaging, analytical support, and oral solid dose manufacturing.

With nine manufacturing facilities across North America and Taiwan (including two operating as Bora Biologics), Bora supports a broad range of dosage forms and global market requirements while maintaining a strong focus on quality, operational execution, and long-term customer partnership. The session highlights Bora’s approach to rapid project onboarding, digitally enabled collaboration, and integrated support across the manufacturing lifecycle designed to support evolving customer needs.

What you’ll learn

• Bora’s global CDMO network and small molecule drug product capabilities
• How Bora initiates projects in as little as 7 to 10 days through integrated onboarding and tech transfer workflows
• The development, pilot-scale, and commercial manufacturing capabilities available at the Maple Grove facility
• Bora’s oral solid dose manufacturing expertise and scalable production infrastructure
• Bora’s approach to quality, regulatory compliance, and operational execution